Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT00317811. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Testing JNJ-42756493 In Combination With Dexamethasone in Multiple Myeloma That Came Back After a Period of Improvement
ClinicalTrials.gov study NCT02952573. IPD Sharing: NO. Countries: 1. Publications: 1.
Kidney Therapy for Free Light Chain Removal in Patients With Multiple Myeloma & Cast Nephropathy
ClinicalTrials.gov study NCT02358980. IPD Sharing: Not stated. Countries: 1. Publications: 6.
A Study of Selinexor (Seli) + Low-dose Dexamethasone (LDD) in Penta-refractory Multiple Myeloma (MM), Seli and Bortezomib + LDD in Triple-class Refractory MM.
ClinicalTrials.gov study NCT04414475. IPD Sharing: UNDECIDED. Countries: 2. Publications: 1.
Clarithromycin in Multiple Myeloma Induction Therapy
ClinicalTrials.gov study NCT02573935. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
ClinicalTrials.gov study NCT00151203. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
ClinicalTrials.gov study NCT05219721. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Thrombin Generation During the 3 First Cycles of Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT01508416. IPD Sharing: Not stated. Countries: 1. Publications: 0.
STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STE
ClinicalTrials.gov study NCT02215980. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00568880. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00452569. IPD Sharing: Not stated. Countries: 15. Publications: 1.
Engineered Dendritic Cell Vaccines for Multiple Myeloma
ClinicalTrials.gov study NCT06435910. IPD Sharing: NO. Countries: 2. Publications: 2.
Tolerability and Efficacy of Modified VCD Regimens in Previously Untreated Multiple Myeloma.
ClinicalTrials.gov study NCT02086942. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Thalidomide to Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov study NCT00218855. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Level of Physical Activity and Its Associations With Fatigue and Quality of Life in Multiple Myeloma Survivors
ClinicalTrials.gov study NCT02078518. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Ixazomib -Daratumumab Without Dexamethasone (IDara) in Elderly Relapse Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03757221. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Phase 1 Study of CNTO 328 (Siltuximab) in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01309412. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Fall Risk Assessment and an Exercise Intervention for Prevention of Falls in Multiple Myeloma Patients
ClinicalTrials.gov study NCT07044427. IPD Sharing: YES. Countries: 1. Publications: 5.
PET Imaging Study of 68Ga-NB381 in Multiple Myeloma
ClinicalTrials.gov study NCT06385652. IPD Sharing: NO. Countries: 1. Publications: 4.
Up-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma
ClinicalTrials.gov study NCT03549442. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.